The impacts of Crocin on serum cytokines concentrations in participants with metabolic syndrome: a double-blind randomized clinical trial study
- PMID: 40817397
- PMCID: VSports注册入口 - PMC12356862
- DOI: 10.1038/s41598-025-15953-2 (V体育官网入口)
The impacts of Crocin on serum cytokines concentrations in participants with metabolic syndrome: a double-blind randomized clinical trial study
VSports注册入口 - Abstract
The aim of this study was to investigate the effect of Crocin on the inflammatory cytokines profile in patients with Metabolic syndrome (Mets). Twenty-eight patients with Mets (15 cases and 13 controls) were randomly selected by the International Diabetes Federation (IDF) definite criteria in a double-blind randomized clinical trial. Participants were divided into two treatment groups, a group received 15 mg of Crocin (two tablets per day), and the other one received a placebo for eight weeks. Inflammatory and growth factors were measured using a sandwich chemiluminescence assay, before and after treatment. Our results indicated that inflammatory factors including IL-2, IL-10, VEGF and INF γ, were significantly reduced (P < 0. 05) in patients with Mets after Crocin treatment. Moreover, no significant difference was detected among the other biochemical factors (lipid profile and FBG) between two groups. The results showed the exclusive impact of Crocin on the reduction of serum inflammatory cytokines. Crocin has the potential to be further investigated as a useful therapeutic factor in inflammatory diseases VSports手机版. Clinical trial registration number: IRCT2013080514279N1, Registration date: 01/02/2015. .
Keywords: Cytokines concentration; Metabolic syndrome; Randomized double-blind clinical trial; Saffron V体育安卓版. .
© 2025. The Author(s).
V体育ios版 - Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests V体育ios版. Ethics approval: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the Mashhad University of Medical Sciences. Consent to participate: Informed consent was obtained from all individual participants included in the study. Consent to publish: Not applicable.
References
-
- Saklayen, M. G. The global epidemic of the metabolic syndrome. Curr. Hypertens. Rep.20 (2), 1–8 (2018). - PMC (VSports注册入口) - PubMed
-
- Engin, A. The definition and prevalence of obesity and metabolic syndrome. Obes. Lipotoxicity2017:1–17 . - PubMed
-
- Mottillo, S. et al. The metabolic syndrome and cardiovascular risk: a systematic review and meta-analysis. J. Am. Coll. Cardiol.56 (14), 1113–1132 (2010). - PubMed
Publication types
- Actions (VSports注册入口)
MeSH terms
- "VSports注册入口" Actions
- Actions (V体育ios版)
- Actions (VSports注册入口)
- "VSports app下载" Actions
- "VSports在线直播" Actions
- "V体育官网" Actions
- "VSports在线直播" Actions
Substances
- VSports注册入口 - Actions
LinkOut - more resources
"VSports注册入口" Full Text Sources
"VSports在线直播" Medical
